Efficacy and Safety of Once Daily Dosing Compared to Twice Daily Dosing of Nitisinone in HT-1
Condition(s):Hereditary Tyrosinemia, Type ILast Updated:November 11, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Hereditary Tyrosinemia, Type ILast Updated:November 11, 2015Completed
Condition(s):Hereditary Tyrosinemia, Type ILast Updated:February 7, 2024Recruiting
Condition(s):Albinism; Vision LossLast Updated:February 26, 2019Completed
Condition(s):Hereditary Tyrosinemia, Type ILast Updated:January 14, 2020Completed
Condition(s):AlkaptonuriaLast Updated:May 31, 2018Unknown status
Condition(s):AlkaptonuriaLast Updated:April 22, 2021Completed
Condition(s):Hereditary Tyrosinemia, Type ILast Updated:June 14, 2017Completed
Condition(s):HealthyLast Updated:October 12, 2021Completed
Condition(s):Hereditary Tyrosinemia, Type ILast Updated:March 15, 2017Completed
Condition(s):AlkaptonuriaLast Updated:August 26, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.